You just read:

IDEAYA Announces First Patient Dosing of IDE196 for Solid Tumors outside of Uveal Melanoma and a Collaboration with Foundation Medicine in support of its Tumor-Agnostic GNAQ/11 Basket Trial

News provided by

IDEAYA Biosciences, Inc.

Oct 08, 2019, 06:00 ET